Intracranial aneurysms in autosomal dominant polycystic kidney disease  by Chauveau, Dominique et al.
Kidney International, Vol. 45 (1994), pp. 1140—1146
Intracranial aneurysms in autosomal dominant polycystic
kidney disease
DOMINIQUE CHAUVEAU, YVES PIRSON, CHRISTINE VERELLEN-DUMOULIN, ANNE MACNICOL,
ANA GONZALO, and JEAN-PIERRE GRUNFELD
Department of Nephrology, Hôpital Necker, Paris, France; Department of Medicine and Center for Human Genetics, Cliniques Saint-Luc,
Brussel, Belgium; Department of Medicine, University of Edinburgh, Scotland, United Kingdom; and Nephrology Unit, Hospital Ramon y
Cain!, Madrid, Spain
Intracranial aneurysm in autosomal dominant polycystic kidney dis-
ease. Rupture of intracranial aneurysm (ICA) is a rare but severe
manifestation of autosomal dominant polycystic kidney disease
(ADPKD). In order to assess its natural history, to determine the
prevalence of familial aggregation and to document linkage to PKD1
locus, we conducted a retrospective study on 77 ADPKD patients from
64 families presenting with ruptured (N = 71) or unruptured (N = 6)
aneurysm. Information was collected on kidney disease, intracranial
aneurysm and family history. Linkage to PKDI locus was examined by
five probes to obtain informative flanking markers. Within one year
prior to rupture, blood pressure was normal in 29% of the patients. At
the time of rupture, mean age was 39.5 years (range 15 to 69), renal
function was normal in half of the patients and 11% were on renal
replacement therapy. The ruptured aneurysm was usually located on
the middle cerebral artery. Additional intact aneurysms (1 to 6) were
detected in 31% of the patients. Surgical or endovascular treatment was
performed in 54 (76%) patients whereas 17 (24%) had medical manage-
ment only. Rupture of ICA was fatal in seven (10%) patients. On long-
term follow-up 27 (38%) were left with severe disablement. Five
patients bled from another aneurysm 2 days to 14 years after initial
rupture. Only two of six patients with unruptured aneurysm alone were
treated on a prophylactic basis. No clinical marker associated with
aneurysm was found. A family history of aneurysm rupture was
demonstrated in 10 (18%) kindreds. Linkage to the PKDI locus was
established in two of three tested families. These data suggest that ICA
rupture in ADPKD patients entails significant mortality and morbidity,
close to the rates reported in non-ADPKD patients. Prophylactic
screening for unruptured aneurysms should focus on patients with a
previous episode of rupture, and probably on those with a familial
history of aneurysm.
The defective gene responsible for most autosomal dominant
polycystic kidney disease (ADPKD) was localized in 1985 to a
locus designated PKD 1 on the short arm of chromosome 16 [1].
Subsequently, genetic heterogeneity was proven as no linkage
with PKD1 was detected in some rare families [2, 31. Intracra-
nial aneurysm (ICA) is the major vascular abnormality reported
in ADPKD. It is widely believed that this association is more
frequent than due to chance alone, although its true prevalence
has not been adequately assessed. Since the recognition that
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such aneurysms may progress to rupture [4] leading to sub-
arachnoid, intraventricular or intracerebral hemorrhage, it is
considered to be one of the most serious complications of
ADPKD [5]. As cerebral hemorrhage frequently occurs without
associated aneurysm in patients with ADPKD [6], computed
tomography (CT) and/or cerebral angiography are warranted to
ascertain the cause of the bleed. Despite substantial improve-
ments in neurological imaging, there is little information on the
natural history of ICA in ADPKD patients. Whether the exis-
tence of ICA is associated with a particular clinical profile of
ADPKD is also unknown. However, the existence of familial
clustering of intracranial aneurysms among ADPKD patients
has been demonstrated in a recent study [7], although detailed
neurological assessment and genetic data were missing.
Within a Concerted Action Group ("Toward the Prevention
of Renal Failure caused by Polycystic Kidney Disease"),
supported by the European Community, we therefore initiated
a multicenter study on ICA in ADPKD with the aims of
delineating the profile and outcome of ADPKD patients with
ruptured or unruptured ICA, and of performing genetic linkage
studies to the PKD1 locus in selected families having several
members affected by ICA.
Methods
Patients
We contacted nephrologists in six European countries to
identify patients with ADPKD and intracranial aneurysms on a
retrospective basis. Diagnosis of ADPKD was supported by
both usual clinical and ultrasonographic criteria [8], or on
autopsy report. Intracranial aneurysms were identified by cere-
bral artenography, cranial computed tomography or both in
patients with unruptured or ruptured aneurysms. In patients
with intracranial hemorrhage (subarachnoid hemorrhage and
cerebral hematoma), bleeding had to be clearly attributed to
ruptured aneurysm. Patients with angiogram-negative sub-
arachnoid hemorrhage were excluded from the study.
A detailed questionnaire was then sent to each participating
nephrologist. The first patient identified in each family was
designated as the index case. The questionnaire sought infor-
mation on kidney disease including presentation, blood pres-
sure in the year prior to rupture, antihypertensive therapy and
renal function. We requested data on the presentation, size and
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ADPKD patients.
location of ICA on the circle of Willis and its branches,
subsequent treatment, recurrent rupture and clinical outcome.
Hypertension was defined as blood pressure above or equal to
160 mm Hg systolic or 95 mm Hg diastolic or use of antihyper-
tensive drug. Renal impairment was defined as serum creatinine
concentration above 120 mol/liter. The diagnosis of cerebral
aneurysm in relatives with established polycystic kidney dis-
ease was considered as proven if identified by arteriography, or
probable if intracranial hemorrhage had occurred before 40
years of age.
Linkage analysis
Linkage to the PKD1 locus was examined in three families
having two or three relatives with proven intracranial aneu-
rysm. Blood samples from 6, 24 and 14 members were analyzed
in families A, B and C, respectively. Standard methods were
used for DNA extraction, digestion with restriction enzymes,
electrophoresis, Southern blotting and hybridization. A set of
five probes (3' HVR, pGG1, p26.6, VK5b and 218 EP6) pro-
vided by the Concerted Action Group was tested to obtain
informative flanking markers [9].
The MLINK subprogram of the computer program LINK-
AGE (version 5.03) was used to calculate lod scores [10].
Two-point analysis lod scores were calculated with the 3'HVR
informative marker. Multipoint analysis was performed with
the distal marker 3'HVR and one proximal marker (VK5b or
218 EP6).
Table 1. Sites of the ruptured cerebral aneurysms in 71 ADPKD
patients presenting with a first rupture
Aneurysm site Number of cases
Internal carotid artery 4
Anterior communicating artery 12
Middle cerebral artery 30
Anterior cerebral artery 8
Basilar bifurcation of posterior cerebral artery 5
Posterior communicating artery 1
Not specified II
Results
Data were collected on 77 patients (45 female and 32 male)
from 64 families. At the time of diagnosis, aneurysmal rupture
had occurred in 71 patients. In the six remaining patients the
aneurysm was unruptured.
Ruptured aneurysms
Age at rupture ranged from 15 to 69 years (mean 39.5) and
was under 21 years in seven patients (Fig. 1). On admission 51
patients had symptoms of uncomplicated subarachnoid hemor-
rhage with signs of meningeal irritation only, whereas 20
patients had focal neurological deficits or loss of consciousness.
The diagnostic procedure was cerebral arteriography in 64
patients and cranial CT in 7. The site of aneurysm was specified
in 60 cases. All aneurysms were saccular. The ruptured aneu-
rysm was most frequently located on the middle cerebral artery
(Table 1). Four-vessel arteriography was performed in 55 pa-
tients and disclosed additional intact aneurysms in 17 patients (8
females, 9 males). The size of the ruptured aneurysm was
known in nine patients and ranged from 2.5 to 27 mm.
Blood pressure had been recorded in 38 patients within the
year prior to aneurysmal rupture. Eleven patients who were not
taking antihypertensive therapy had blood pressure below
160/95 mm Hg. At the time of rupture, renal function was
known in 64 patients: 32 had normal serum creatinine, 24 had
chronic renal failure, six patients were on regular hemodialysis,
and two had a functioning kidney graft. Aneurysm rupture led
to the diagnosis of previously unknown ADKPD in seven
patients.
Following aneurysm rupture, 17 patients did not undergo
surgery either because their clinical condition was considered
too poor (N 14, including four patients who died from
cerebral hemorrhage within 5 days), or the aneurysm was
unclippable because of its location (N =3). Rebleeding from the
same aneurysm occurred subsequently in four patients after an
interval of 4 months to 29 years, leading to death in one of them
and to successful surgical treatment in another one. At the end
of follow-up, among the 17 non-operated patients ten patients
had died (5 from aneurysmal rupture and 5 from unrelated
conditions) and seven were alive, after a mean follow-up of 8.1
years (range 1 to 30). All but one were without major neurolog-
ical deficit. Four were on regular dialysis, one had a functioning
kidney graft and two had chronic renal failure.
Fifty-four patients received surgical or endovascular treat-
ment. The aneurysm was not clipped in two cases (wrapping in
one; endovascular occlusion of the parent vessel in the other).
Aneurysmal rupture recurred in both patients, 4 and 15 months
later, leading to death in one case and severe deficit in the other.
<20 30 40 50 60 >70
Decennial age group, years
distribution of first aneurysmal rupture in 71
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Table 2. Outcome of 71 ADPKD patients after the first rupture of an
intracranial aneurysm
Early
death
 3
months
Survival > 3 months
Lost to
follow-up
Major
sequellae
Good
recovery
Late death
due to
recurrent
hemorrhage
Operated(N = 54)
Non-operated(N = 17)
Total
(N = 71)
3
4
7
2
0
2
22
5
27
24
7
31
3
1
4
The ruptured aneurysm was clipped in 52 cases; three patients
died within three months of the surgical procedure including
one who ruptured a second aneurysm located at a mirror site of
the Willis circle. Two further patients were lost to follow-up.
The 47 remaining patients were followed for a mean of 8.3 years
(range 1 to 18 years). Further rupture of another aneurysm
occurred in four cases, 6 to 14 years later. In three cases
previously reported [11], the second aneurysm was retrospec-
tively not detectable on the four-vessel angiography performed
at the time of the initial rupture. One of these patients had two
episodes of rebleeding, the third attack leading to death. Two
patients were left with severe neurological impairment. The last
patient had seven aneurysms on initial angiography, only two of
which were clipped. He died from recurrent rupture six years
after the first episode. At the end of the follow-up the 43
remaining patients whose aneurysm had been clipped did not
have recurrence of ICA rupture. Nineteen patients had persis-
tent severe neurological impairment while 24 were asymptom-
atic (Table 2).
Renal manifestations related to ADPKD on follow-up in-
cluded hypertension diagnosed in 79% of the patients at a mean
age of 36.4 (range 6 to 60) years, and end-stage renal failure in
29 patients at a mean age of 46 (range 10 to 66) years. Liver
cysts and mitral valve abnormalities were observed in 60% (31
of 51) and 22% (9 of 41) of the patients, respectively. No
abdominal aortic aneurysm was diagnosed in the 16 patients
studied by echography or computed tomography.
To determine whether renal- and extrarenal disease might
share an unusual profile in the seven patients whose rupture
occurred at a very young age ( 20 years), we compared them
to the 64 remaining patients. A striking female preponderance (6
of 7) characterized the younger group. There was no statistical
difference with respect to the mean number of aneurysms per
patient or the family history of aneurysm rupture.
Unruptured aneurysm
Six female patients (mean age 48.5 years, range 24 to 66) with
non-ruptured aneurysm were taken as index cases. Manifesta-
tions were mass lesions (N = 2), cerebral ischemia (N 1) or
persistent headache with family history of rupture (N =2), and
in one asymptomatic patient the aneurysm was detected by
screening. Three of the six had multiple aneurysms, two in two
patients and three in one. One patient died after prophylactic
surgery. Selective endovascular obliteration was successfully
performed in another. One patient was not a suitable candidate
for surgery and died of progressive dementia two years after
detection of aneurysm. In two patients, aneurysms were unclip-
pable. In the last one, the size of the detected aneurysm was
judged too small to carry out surgical repair. Four patients were
alive without neurological impairment after a mean follow-up of
1.5 years (range 1 to 2).
In addition, 29 unruptured aneurysms were detected in
association with a ruptured aneurysm in 17 patients (see above):
1 in 10, 2 in 5, 3 in 1 and 7 in 1 patients. Nine of these were
operated on, without additional morbidity or mortality. Among
20 incidental aneurysms which were initially not operated on,
only three bled during a 88 patient-years of follow-up (mean
follow-up 4.4 years, range 1 to 17).
Family history
Among 55 pedigrees available, all but one demonstrated a
family history of ADPKD. Ten (18%) index patients had a
family history of intracranial aneurysm either proven by arte-
riography (N = 6) or regarded as highly probable (N = 4).
Affected relatives were siblings in three families, parents in five
and both in two. No father to son transmission was recorded.
The mean number of ADPKD affected patients per family was
similar in families with (N 5.2) and without (N = 4.1) family
history of aneurysm. Patients of both groups were comparable
as regards diastolic blood pressure prior to the rupture, age and
serum creatinine at rupture, and number of unruptured aneu-
rysms. Only systolic blood pressure was significantly higher in
the group without family history both prior to rupture and at last
follow-up (160.1 vs. 131.7 and 144.2 vs. 134.9 respectively,P<
0.05).
Interestingly, one index case who presented with subarach-
noid hemorrhage at age 20 had a monozygotic twin currently
free of stroke at age 48 (Fig. 2, family C). At age 47, both were
examined by magnetic resonance (MR) imaging. Two aneu-
rysms were detected in the former (the largest one was clipped)
and none in the latter. Hypertension had been untreated in the
former and treated for 20 years in the latter.
Genetic linkage study
Lod scores obtained in the two-point linkage analysis in
families A, B and C were 0.90, 2.83 and 1.94, respectively (Fig.
2). After multipoint analysis with flanking markers, lod scores
increased to 1.01, 3.06 and 2.18, respectively, suggesting link-
age to PKD1 locus in at least families B and C.
Discussion
Our primary aim was to shed light on the epidemiology and
outcome of intracranial aneurysms in ADPKD patients. Recent
studies dealt with asymptomatic ICA [7] or did not consider the
long-term follow-up [13]. It may be argued that our retrospec-
tive study involves several biases. As demonstration of both
polycystic kidney disease and aneurysm rupture were prereq-
uisite for inclusion, we probably missed patients with the
mildest forms of renal disease. The most severe forms of
intracranial hemorrhage leading to early death before any
investigation were not included, and may account for 12 to 20%
of aneurysmal rupture in non-ADPKD patients [14]. On the
other hand, the mildest forms of uncomplicated subarachnoid
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Fig. 2. Pedigrees in three families with
aneurysmal rupture in two or more relatives.
Symbols are: ( ) male and female with
ADPKD; (Jo) ruptured intracranial
aneurysm; () unruptured intracranial
aneurysm; (31) age at discovery of aneurysm;
(N or 4>) not examined.
patients with aneurysm rupture. We found that aneurysm
rupture may be the initial manifestation of ADPKD. This event
is not restricted to patients with advanced renal disease as 29%
were normotensive and 50% had normal renal function at the
time of the rupture. It may occur in youth: 10% of the patients
were 20-years-old or less. To our knowledge, the youngest
ADPKD patient reported with subarachnoid bleeding was a
6-year-old boy [15]. Female preponderance at a young age is
characteristic of ruptured intracranial aneurysm in ADPKD and
has not been observed in patients without ADPKD
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hemorrhage may have not been investigated as well. Despite
typical presentation, patients with angiogram-negative sub-
arachnoid hemorrhage were excluded. Furthermore, heteroge-
neity inherent to the multicenter design of the study probably
affected the accuracy of collecting family histories and the
approach to medical and surgical management of ICA among
participating institutions. This must be kept in mind to interpret
our results.
Despite these shortcomings, our study provides valuable
information on the clinical profile of a large number of ADPKD
1144 Chauveau et a!: Intracranial aneurys,ns in ADPKD
Aneurysm rupture entails a 46% risk of morbidity and mor-
tality at three months in ADPKD patients. This is close to the
corresponding figure in non-ADPKD patients, which ranges
from 33 to 47% at six months in large surveys [16, 171. At six
months, a 55% mortality rate of subarachnoidal hemorrhage in
ADPKD has been reported [13]. Indeed a less favorable out-
come in ADPKD patients is to be expected because of the high
prevalence of both hypertension and renal failure. Low blood
pressure level at admission has been associated to be related to
a favorable outcome in aneurysm rupture among non-ADPKD
patients [17]. In our series, although chronic hypertension had
been diagnosed in 71% of 38 patients whose blood pressure had
been recorded within one year prior to rupture, we were not
aware of blood pressure at admission. Poor outcome (death or
severe neurologic impairment) was in the same range in previ-
ously normotensive and hypertensive patients (54 and 51%,
respectively). From our series we thus cannot categorically
assess the effect of blood pressure on outcome. Renal failure,
present in 50% of our patients but in only 0.6% of the Cooper-
ative Study [17], may conceivably worsen the prognosis initially
by facilitating protracted bleeding or premature rebleeding
because of the well-known platelet dysfunction related to
uremia, or by increasing the complexity of medical management
at a later stage. The case-fatality rates at three months were
15% and 6% among patients with renal failure or normal renal
function, respectively. On the other hand, mean age at rupture
in ADPKD patients was ten years below that reported in
non-ADPKD patients [17] which may have, in turn, shifted
toward a better outcome in our patients.
Once ruptured, whatever the size of the intracranial aneu-
rysm, it must be selectively excluded from the cerebral circu-
lation to prevent further bleeding, usually by clipping at the
neck. In some centers, endovascular obliteration or parent
vessel occlusion has been used in aneurysm with a large neck or
in otherwise untreatable lesions, mainly of the posterior circu-
lation [18]. Both procedures carry a significant risk. Our cumu-
lative post-operative mortality rate of 9% is close to that
reported in non-ADPKD patients [17]. Recent data suggest that
mortality could be reduced by using drugs able to prevent
vasospasm and limit cerebral ischemia, such as certain calcium
antagonists [19].
A striking finding that emerges from this study is the risk of
recurrent hemorrhage from another aneurysm on long-term
follow-up. Such an event was observed in five cases. Of interest
in three of them the aneurysm responsible for the second
rupture was not detected at the time of the first one [11]. This
phenomenon may have several explanations. The possibility
that a second aneurysm was missed [20] on both pre- and
postoperative angiogram seems unlikely. Progressive enlarge-
ment of a pre-existent microaneurysm, or rapid growth of a new
aneurysm are more likely explanations. Whatever the mecha-
nism, it is clear that intracranial aneurysm may develop over
time in ADPKD. Taken together with the multiplicity of aneu-
rysms (26% in this series, a figure close to the 18 to 19%
reported elsewhere [17, 20]) these findings suggest that intra-
cranial aneurysms reflect a diffuse and progressive disease of
the cerebral arterial tree in ADPKD. On clinical practice, it
implicates that ADPKD patients who have suffered ICA rupture
should be regularly examined to detect the growth of new
aneurysms.
The importance of heredity in the development of berry
aneurysms has repeatedly been reported in non-ADPKD fami-
lies with several relatives having ruptured aneurysms [2 1—23].
One recent study concluded that 7% of all ICA may be familial
[24]. A dominant pattern of inheritance has been suggested [21,
23]. No chromosomal assignment has so far been reported. In
ADPKD patients, we found a family history of aneurysm
rupture in 10 out of 55 index cases (18%), a figure in keeping
with the 22% familial prevalence reported by Schievink et al
[13]. However, criteria for diagnosis of aneurysm rupture in
relatives were not provided in the latter study. In the present
series aneurysm rupture in one or more relatives was docu-
mented in six families by angiogram, and was considered as
highly probable in four other families on the basis of subarach-
noid hemorrhage occurring before the age of 40 years. This
upper age limit was chosen to preclude the inclusion of relatives
with stroke mimicking but unrelated to aneurysm rupture.
Familial aggregation of cerebral aneurysm is suggested by
two of our families (Fig. 2, family A and B) as well as in two
previously reported observations [25, 26] in whom more than
two ADPKD-affected relatives also had intracranial aneurysm.
It is unlikely that such clusters arose by chance alone. The
young age of the affected patients provides further support to
attributing the formation of aneurysms or subsequent growth to
a genetic predisposition in ADPKD. Further evidence for
familial clustering of cerebral aneurysm was recently given
using magnetic resonance (MR) angiography in asymptomatic
ADPKD patients which suggested a 4.4 relative risk if a positive
family history of ICA is elicited [13]. Analysis of our pedigrees
is consistent with a dominant pattern of inheritance.
Genetic analysis performed in two families strongly suggests
that the disease is linked to the PKD1 locus. This association is
not unexpected as the PKD1 gene accounts for 85% of ADPKD
in Europe [27]. Whether specific mutations of the PKD 1 gene
are associated with cerebral aneurysm and may account for
phenotypic heterogeneity between families warrants direct
identification of the responsible gene(s). Interestingly, aneu-
rysm rupture also affected only one single member of a large
APDKD family unlinked to the PKD 1 locus [2].
The biochemical abnormality leading to the formation of
saccular ICA has never been studied in ADPKD. Collagen type
III abnormalities have been demonstrated in half of patients
with ICA in the absence of widespread connective tissue
disorder [28]. Cerebral aneurysms may also be part of two
dominantly inherited connective tissue disorders, the vascular
form of Ehlers-Danlos syndrome (type IV) which results from a
mutation in the gene for type III procollagen and Marfan's
syndrome. These data suggest that collagen genes could also be
candidate genes for ICA associated to ADPKD.
If genetic susceptibility to cerebral aneurysms exists in
ADPKD, the reason for the low incidence of familial clusters of
ICA rupture is not clear. It is tempting to attribute a significant
role to environmental factors in the growth and subsequent
rupture of ICA. Their influence could account for both the high
prevalence of sporadic cases and non-concomitant develop-
ment of cerebral aneurysm in identical twins in family C. As
suggested by twins' history, uncontrolled hypertension could
have promoted aneurysm enlargement in one of them. Apart
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from hypertension, cigarette smoking [29] and alcohol con-
sumption are also thought to be risk factors for subarachnoid
hemorrhage in non-ADPKD patients.
Despite improvement in neuroanesthetic and surgical or
endovascular procedures, a decline in mortality after aneurys-
mal rupture remains disputed [14], raising the question of
investigation for occult aneurysm in ADPKD patients. From a
practical point of view, no renal or extrarenal manifestation of
ADPKD was found to be of value to predict the rupture of
cerebral aneurysm; renal disease was unremarkable and liver
cysts and mitral-valve abnormalities were not more frequent in
our patients than in the general ADPKD population [30, 31].
This study was not designed to assess an association between
severe polycystic liver disease and cerebral aneurysm sug-
gested in a single study [7]. The question of routine screening
for ICA with cerebral angiography was assessed by Levey,
Pauker and Kassirer. Using decision analysis they concluded
that such screening was not warranted in all ADPKD patient
[32]. Furthermore, the use of this technique might be associated
with a higher complication rate in ADPKD [12]. Noninvasive
tests such as CT-scan and MR imaging are of limited values
because of their low specificity to diagnose small ICA [7, 121.
MR angiography, which can define the circle of Willis suffi-
ciently to detect cerebral aneurysms as small as 1.5 mm, has
been performed in a series of 85 asymptomatic ADPKD patients
and detected a definite aneurysm in nine (11%) [7]. The size of
the aneurysms was less than 6.5 mm in diameter. Most neuro-
surgeons would be reluctant to perform prophylactic cure of
aneurysms measuring less than 10 mm in diameter, because the
annual risk of rupture is known to be low. It thus appears that
widespread screening examination in unselected ADPKD pa-
tients remains unrewarding. It seems reasonable to restrict
noninvasive screening for occult aneurysms to patients at high
risk of development of ICA. There is no doubt that patients
surviving a first rupture must be regularly restudied. Due to the
possibility of familial clustering, prophylactic investigation
should be performed in asymptomatic patients having two
relatives or more who have experienced aneurysm rupture. In
view of our data, we suggest that such screening start as early
as 18 years of age. These recommendations might apply as well
to those with only one affected relative. A prospective study is
anyway required to prove the usefulness of familial screening
and the periodicity of repeated examination. Screening in
asymptomatic patients has also been advocated in individual
setting, such as major vascular surgery [33].
Obviously, all patients with the classic presentation of sub-
arachnoid hemorrhage must be rapidly investigated. The diag-
nostic importance of a warning headache in non-ADPKD
patients has been emphasized [34]. A sentinel aneurysmal leak
should indeed be suspected in a patient with severe unusual
pain in the head or face. It could precede by weeks or months
as many as half of the cases of aneurysm rupture. Every
ADPKD patient should be aware of the meaning of such
symptomatology.
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